Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells
Do Hyung Kim,1,2,* Young-Il Jeong,1,* Chung-Wook Chung,1 Cy Hyun Kim,1,2 Tae Won Kwak,1 Hye Myeong Lee,1 Dae Hwan Kang1,21National Research and Development Center for Hepatobiliary Cancer, Pusan National University Yangsan Hospital, 2School of Medicine, Pusan National University, Yangsan, Gyeongsang...
Guardado en:
Autores principales: | Kim DH, Jeong YI, Chung CW, Kim CH, Kwak TW, Lee HM, Kang DH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a24dbd7dffcd426d9c4762c3d3a588ea |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vorinostat-eluting poly(DL-lactide-co-glycolide) nanofiber-coated stent for inhibition of cholangiocarcinoma cells
por: Kwak TW, et al.
Publicado: (2017) -
Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells
por: Kim CH, et al.
Publicado: (2013) -
Effect of 5-aminolevulinic acid-based photodynamic therapy via reactive oxygen species in human cholangiocarcinoma cells
por: Kang DH, et al.
Publicado: (2011) -
Dextran-b-poly(L-histidine) copolymer nanoparticles for pH-responsive drug delivery to tumor cells
por: Hwang JH, et al.
Publicado: (2013) -
5-aminolevulinic acid-incorporated poly(vinyl alcohol) nanofiber-coated metal stent for application in photodynamic therapy
por: Kang DH, et al.
Publicado: (2012)